The oocyte is a remarkable haploid cell that carries all the information needed to undergo a complex maturation process to become a fertilizable egg and possesses the ability to initiate the early stages of development after fertilization. During the period of oocyte growth, mRNAs are synthesized and stored, and these mRNAs are very stable at this time, with a half-life of approximately 12 days in mouse oocytes [1,2]. By the time the oocyte reaches its full size, transcription ceases, so the oocyte must rely on these stored maternal mRNAs for oocyte maturation, fertilization, and early embryonic development until zygotic gene activation, which occurs at the 2-cell stage in the mouse [3]. Paradoxically, although maternal mRNAs are necessary for oocyte maturation and early development, the period of oocyte maturation through the 2-cell stage is marked by a dramatic degradation of select maternal transcripts, accounting for an approximately 20% decrease in the total RNA in the oocyte [4,5]. This loss of mRNAs is necessary to remove the maternal genome so that the oocyte can undergo the maternal-to-embryonic transition to metamorphose into totipotent blastomeres [6]. In this issue of Biology of Reproduction, Ma et al.[7] answer some of the unknown questions about how maternal mRNA degradation occurs in the mouse oocyte during oocyte maturation.Eukaryotic mRNAs have a 5 0 cap structure and a 3 0 poly(A) tail that regulate translation and mRNA stability [8]. Deadenylation of the 3 0 poly(A) tail usually triggers mRNA degradation, and indeed, deadenylation is apparent in mouse oocytes during meiotic maturation [4,9]. Removal of the 5 0 -monomethyl guanosine cap (decapping) renders mRNA susceptible to the 5 0 !3 0 degradation pathway by exposing them to exonucleases that rapidly degrade the mRNA from the 5 0 end [8].Earlier work, reported largely by the Schultz lab, has shown that the stability of mRNAs during oocyte growth is maintained by the protein MSY2 (mouse specific Y-box protein 2). MSY2 is an abundant, germ cell-specific Y-box protein that binds to RNA in vitro [10,11]. Reducing MSY2 protein using a transgenic RNA interference (RNAi) approach leads to a decrease in protein synthesis and in the total amount of RNA; in turn, this leads to abnormal meiotic spindle formation and low incidence of egg activation after fertilization [12]. Furthermore, Msy2 À/À oocytes have a reduced growth rate compared with wild-type oocytes; these knockout oocytes fail to become transcriptionally quiescent when fully grown, display a decrease in mRNA stability, and do not mature properly [13]. A progressive loss of oocytes and follicles as well as disrupted ovulation also occur in Msy2 À/À mice, with the result that these mice are infertile [14]. MSY2 is phosphorylated during oocyte maturation by CDC2A, a protein that is activated very early in the oocyte maturation process [10,15]. By the time the oocyte reaches the metaphase II stage, essentially all the MSY2 protein is phosphorylated [10]. Phosphorylation of MSY2 is correlated wit...